Skip to content

Opening book details…

About this Medicine article

Phase I dose escalation study of the PI3kinase pathway inhibitor BKM120 and the oral poly (ADP ribose) polymerase (PARP) inhibitor olaparib for the treatment of high-grade serous ovarian and breast cancer by Matulonis, U.A.; Wulf, G.M.; Barry, W.T.; Birrer, M.; Westin, S.N.; Farooq, S.; Bell-McGuinn, K.M.; Obermayer, E.; Whalen, C.; Spagnoletti, T.; Luo, W.; Liu, H.; Hok, R.C.; Aghajanian, C.; Solit, D.B.; Mills, G.B.; Taylor, B.S.; Won, H.; Berger, M.F.; Palakurthi, S.; Liu, J.; Cantley, L.C.; Winer, E. is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Matulonis, U.A.; Wulf, G.M.; Barry, W.T.; Birrer, M.; Westin, S.N.; Farooq, S.; Bell-McGuinn, K.M.; Obermayer, E.; Whalen, C.; Spagnoletti, T.; Luo, W.; Liu, H.; Hok, R.C.; Aghajanian, C.; Solit, D.B.; Mills, G.B.; Taylor, B.S.; Won, H.; Berger, M.F.; Palakurthi, S.; Liu, J.; Cantley, L.C.; Winer, E.
Publisher
Oxford University Press; Elsevier BV (ISSN 0923-7534)
Published
2017
Field
Medicine (Health Sciences)

More by Matulonis, U.A.; Wulf, G.M.; Barry, W.T.; Birrer, M.; Westin, S.N.; Farooq, S.; Bell-McGuinn, K.M.; Obermayer, E.; Whalen, C.; Spagnoletti, T.; Luo, W.; Liu, H.; Hok, R.C.; Aghajanian, C.; Solit, D.B.; Mills, G.B.; Taylor, B.S.; Won, H.; Berger, M.F.; Palakurthi, S.; Liu, J.; Cantley, L.C.; Winer, E.

Browse all works by Matulonis, U.A.; Wulf, G.M.; Barry, W.T.; Birrer, M.; Westin, S.N.; Farooq, S.; Bell-McGuinn, K.M.; Obermayer, E.; Whalen, C.; Spagnoletti, T.; Luo, W.; Liu, H.; Hok, R.C.; Aghajanian, C.; Solit, D.B.; Mills, G.B.; Taylor, B.S.; Won, H.; Berger, M.F.; Palakurthi, S.; Liu, J.; Cantley, L.C.; Winer, E.